Evidence map›Paper›PMID 34201610›Full record

ArticleInternational journal of molecular sciences2021

Membrane Interactions Accelerate the Self-Aggregation of Huntingtin Exon 1 Fragments in a Polyglutamine Length-Dependent Manner.

Arnaud Marquette, Christopher Aisenbrey, Burkhard Bechinger

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Arnaud MarquetteChemistry Institute UMR7177, University of Strasbourg/CNRS, 67000 Strasbourg, France.
Christopher AisenbreyChemistry Institute UMR7177, University of Strasbourg/CNRS, 67000 Strasbourg, France.
Burkhard BechingerChemistry Institute UMR7177, University of Strasbourg/CNRS, 67000 Strasbourg, France.ORCID 0000-0001-5719-6073
Centre National de la Recherche Scientifique · FR

Funding

Agence Nationale de la Recherche MemPepSyn 14-CE34-0001-01, InMembrane 15-CE11-0017-01, Biosupramol 17-CE18-0033-3 and the LabEx Chemistry of Complex Systems 10-LABX-0026_CSCCHDI Foundation exploration grantRTRA Chemistry of Complex Systems support
6 · The paper itself

Abstract

The accumulation of aggregated protein is a typical hallmark of many human neurodegenerative disorders, including polyglutamine-related diseases such as chorea Huntington. Misfolding of the amyloidogenic proteins gives rise to self-assembled complexes and fibres. The huntingtin protein is characterised by a segment of consecutive glutamines which, when exceeding ~ 37 residues, results in the occurrence of the disease. Furthermore, it has also been demonstrated that the 17-residue amino-terminal domain of the protein (htt17), located upstream of this polyglutamine tract, strongly correlates with aggregate formation and pathology. Here, we demonstrate that membrane interactions strongly accelerate the oligomerisation and β-amyloid fibril formation of htt17-polyglutamine segments. By using a combination of biophysical approaches, the kinetics of fibre formation is investigated and found to be strongly dependent on the presence of lipids, the length of the polyQ expansion, and the polypeptide-to-lipid ratio. Finally, the implications for therapeutic approaches are discussed.

Indexed as

BenzothiazolesCell MembraneCircular DichroismDynamic Light ScatteringExonsFluorescenceHumansHuntingtin ProteinLipid BilayersPeptide FragmentsPeptidesBenzothiazolesHTT protein, humanHuntingtin ProteinLipid BilayersPeptide FragmentsPeptidespolyglutaminethioflavin Tamyloidcircular dichroismdynamic light scatteringhtt17huntingtinHuntington’s diseasemembrane-driven aggregationpeptide-lipid interactionsthioflavin T fluorescence

Identifiers

PMID34201610
PMCPMC8268948
OpenAlexW3175030937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.